Ammonia inhibits the C-type natriuretic peptide-dependent cyclic GMP synthesis and calcium accumulation in a rat brain endothelial cell line

Neurochem Int. 2008 May;52(6):1160-6. doi: 10.1016/j.neuint.2007.12.005. Epub 2007 Dec 15.

Abstract

Recently we reported a decrease of C-type natriuretic peptide (CNP)-dependent, natriuretic peptide receptor 2 (NPR2)-mediated cyclic GMP (cGMP) synthesis in a non-neuronal compartment of cerebral cortical slices of hyperammonemic rats [Zielińska, M., Fresko, I., Konopacka, A., Felipo, V., Albrecht, J., 2007. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices. Neurotoxicology 28, 1260-1263]. Here we accounted for the possible involvement of cerebral capillary endothelial cells in this response by measuring the effect of ammonia on the CNP-mediated cGMP formation and intracellular calcium ([Ca2+]i) accumulation in a rat cerebral endothelial cell line (RBE-4). We first established that stimulation of cGMP synthesis in RBE-4 cells was coupled to protein kinase G (PKG)-mediated Ca2+ influx from the medium which was inhibited by an L-type channel blocker nimodipine. Ammonia treatment (1h, 5mM NH4Cl) evoked a substantial decrease of CNP-stimulated cGMP synthesis which was related to a decreased binding of CNP to NPR2 receptors, and depressed the CNP-dependent [Ca2+]i accumulation in these cells. Ammonia also abolished the CNP-dependent Ca2+ accumulation in the absence of Na+. In cells incubated with ammonia in the absence of Ca2+ a slight CNP-dependent increase of [Ca2+]i was observed, most likely representing Ca2+ release from intracellular stores. Depression of CNP-dependent cGMP-mediated [Ca2+]i accumulation may contribute to cerebral vascular endothelial dysfunction associated with hyperammonemia or hepatic encephalopathy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Ammonia / metabolism*
  • Ammonia / toxicity
  • Aniline Compounds
  • Animals
  • Binding Sites / drug effects
  • Binding Sites / physiology
  • Binding, Competitive / drug effects
  • Binding, Competitive / physiology
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Calcium Signaling / drug effects
  • Calcium Signaling / physiology
  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Cerebral Arteries / metabolism*
  • Cerebral Arteries / physiopathology
  • Cerebrovascular Circulation / drug effects
  • Cerebrovascular Circulation / physiology
  • Cyclic GMP / biosynthesis*
  • Cyclic GMP-Dependent Protein Kinases / drug effects
  • Cyclic GMP-Dependent Protein Kinases / metabolism
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Hepatic Encephalopathy / metabolism
  • Hepatic Encephalopathy / physiopathology
  • Hyperammonemia / metabolism
  • Hyperammonemia / physiopathology
  • Natriuretic Peptide, C-Type / drug effects
  • Natriuretic Peptide, C-Type / metabolism*
  • Protein Binding / drug effects
  • Protein Binding / physiology
  • Rats
  • Receptors, Atrial Natriuretic Factor / drug effects
  • Receptors, Atrial Natriuretic Factor / metabolism
  • Xanthenes

Substances

  • Aniline Compounds
  • Calcium Channel Blockers
  • Xanthenes
  • Natriuretic Peptide, C-Type
  • Fluo-3
  • Ammonia
  • Cyclic GMP-Dependent Protein Kinases
  • Receptors, Atrial Natriuretic Factor
  • atrial natriuretic factor receptor B
  • Cyclic GMP
  • Calcium